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Introduction {#sec1}
============

During ontogeny, innate and innate-like lymphocytes develop earlier than conventional αβT cells of the adaptive immune system. In mice, innate-like Vγ3^+^ γδT cells are the first T cell population generated in the fetal thymi ([@bib23]). Subsequently, innate-like Vγ4^+^ and Vγ2^+^ γδT cells that possess interleukin (IL)-17-producing capacities (γδT17) are preferentially generated in later fetal and neonatal thymi ([@bib4], [@bib5], [@bib20], [@bib22], [@bib49]). In addition, innate lymphoid cells (ILCs) are also generated more preferentially in fetal thymi than in adult thymi ([@bib7], [@bib8], [@bib58]), which suggests a vital, evolutionarily conserved function of innate or innate-like lymphocytes during the early ontogenic stage.

The fetal/neonatal thymus-derived innate and innate-like lymphocytes have particularly important contribution to establishment of the local immune system in barrier tissues such as the skin. In mice, fetal thymus-derived Vγ3^+^ γδT cells are developmentally programmed with a skin-homing property such as high expression of the skin-homing chemokine receptor CCR10 for their preferential localization into the skin, where they reside mostly in the epidermis and account for the vast majority of dendritic epidermal T cells (DETCs) ([@bib23], [@bib30], [@bib31], [@bib61], [@bib62]). DETCs play important roles in immune defense and homeostatic regulation of the skin ([@bib19], [@bib18], [@bib24], [@bib29]). The perinatal thymus-originated γδT17 cells are found abundantly in the dermis of mice where they are involved in anti-microbial immunity, but during dysregulation they may also contribute to skin inflammation ([@bib4], [@bib5], [@bib20], [@bib49], [@bib55]). ILCs are found abundantly in the skin of adult mice and humans where they play important roles in local immune homeostasis and inflammation ([@bib14], [@bib26], [@bib33], [@bib35], [@bib38], [@bib44], [@bib47], [@bib48], [@bib53], [@bib64]). However, their developmental origin and function in early immune protection of the skin are less understood.

ILCs are a family of innate lymphocytes, which are divided into three groups (1--3) in addition to the conventional natural killer (cNK) cells and lymphoid tissue-inducing (LTi) cells, based on their functional potentials and developmental pathways ([@bib54], [@bib57]). Upon activation, group 1 ILCs (ILC1s) predominantly produce T~H~1-type cytokines such as interferon (IFN)-γ; ILC2s produce T~H~2-type cytokines such as IL-5 and IL-13; and ILC3s produce T~H~17-type cytokines such as IL-17 and IL-22 ([@bib54], [@bib57]). There are overlapping functions between ILC1s and cNK cells in promoting the type 1 immunity ([@bib57]). However, ILC1s and cNK cells are developmentally programmed by different transcription factors ([@bib11], [@bib10], [@bib51], [@bib57]). Functionally, ILC1s produce the cytokines IFN-γ, tumor necrosis factor (TNF)-α, and IL-2 more potently than cNK cells, whereas cNK cells more preferentially express high levels of cell-killing effector molecules such as granzyme B (grzmB) and thus possess more potent cytotoxic capacities than ILC1s ([@bib15], [@bib34], [@bib46], [@bib51], [@bib53]). However, ILC1s could also express certain cell-killing molecules such as granzyme C (grzmC) ([@bib12], [@bib21], [@bib46]), consistent with their overlapping functions with cNK cells.

The skin of adult mice contains predominantly ILC2s and ILC3s, but few ILC1s ([@bib35], [@bib47], [@bib64], [@bib65]). We previously reported that skin ILC2/3s in adult mice originate in skin-draining lymph nodes (sLNs), where their precursors are imprinted by skin-derived dendritic cells to express the skin-homing chemokine receptor CCR10 and associated homing molecules for their skin localization and function in maintenance of skin-resident T cell homeostasis ([@bib64]). However, the development and function of ILCs at fetal/neonatal stages are not regulated in the same fashion as at the adult stage. In this study, we discovered a distinct mechanism of predominant establishment of ILC1s in the skin of fetal and early postnatal stages for regulation of commensal bacterial colonization. We found that like fetal thymus-derived skin-homing innate-like γδT cells, NK1.1^+^ ILC1s generated in fetal thymi are also programmed with preferential acquisition of the CCR10^+^ skin-homing property. Correspondingly, most skin ILCs in neonatal mice are NK1.1^+^ ILC1s, which play an important role in regulation of the skin colonization of commensal bacteria. This finding provides insight into the development of skin-resident ILCs and their function in protection of the barrier tissue at early postnatal stages, a critical temporal window for establishment of tissue homeostasis that profoundly impacts the life-long health of individuals.

Results {#sec2}
=======

Preferential Generation of Skin-Homing NK1.1^+^ ILC1s in Fetal and Neonatal Thymi {#sec2.1}
---------------------------------------------------------------------------------

We previously found that innate-like γδT cells were programmed with a CCR10^+^ skin-homing property during their fetal thymic developmental stages ([@bib30], [@bib31]). To determine whether fetal thymic environments also supported the generation of skin-homing ILCs, we analyzed the expression of CCR10 and related skin-homing molecules on fetal thymic CD3^−^NK1.1^+^ cells, a major subset of innate lymphocytes generated in the fetal thymus ([@bib7]). Indeed, a significant fraction of embryonic day 17 (E17) fetal thymic CD3^−^NK1.1^+^ cells expressed CCR10(EGFP^+^) in CCR10^+/EGFP^ (or CCR10^+/−^ for simplicity) reporter mice in which the coding sequence of one CCR10 allele is replaced by a DNA sequence coding for enhanced green fluorescent protein (EGFP) to report endogenous CCR10 expression ([Figure 1](#fig1){ref-type="fig"}A) ([@bib25], [@bib31]). Like E17 fetal thymi, neonatal (2 days old) thymi also contained a significant percentage of CCR10^+^ CD3^−^NK1.1^+^ cells ([Figure 1](#fig1){ref-type="fig"}A). The percentage of CD3^−^NK1.1^+^ cells drastically decreased in adult thyme, and few expressed CCR10 ([Figure 1](#fig1){ref-type="fig"}A). In addition to the thymus, the primary lymphoid organs fetal liver and adult bone marrow (BM) also support generation of NK1.1^+^ ILCs and/or NK cells ([@bib10]), which, however, did not express CCR10 ([Figure 1](#fig1){ref-type="fig"}A). All CCR10^+^ fetal/neonatal thymic CD3^−^NK1.1^+^ cells expressed CD103 (αE) and β7, two integrins involved in the establishment and retention of lymphocytes in the skin, but not the gut-homing molecule α4β7 integrin ([Figures 1](#fig1){ref-type="fig"}A and 1B). The homing molecule expression pattern of thymic CD3^−^NK1.1^+^ cells is identical to that of fetal thymic skin-homing Vγ3^+^ γδT cells ([@bib31]). These results suggest that fetal/neonatal thymi preferentially support generation of skin-homing NK1.1^+^ innate lymphocytes.Figure 1Preferential Generation of NK1.1^+^ ILC1s with a CCR10^+^ Skin-Homing Property in Fetal and Neonatal Thymi(A) Flow cytometric analysis of CD3^−^NK1.1^+^ cells of indicated lymphoid organs of CCR10^+/EGFP^ mice of different ages (top row) and their expression of CCR10(EGFP) and CD103 (bottom). Data are representative of at least three experiments for each organ.(B) Flow cytometric analysis of CCR10 and β7 or α4β7 on gated CD3^−^NK1.1^+^ thymocytes of E17 fetal CCR10^+/EGFP^ mice.(C) Flow cytometric analysis of CCR10 and indicated surface molecules on gated CD3^−^NK1.1^+^ thymocytes of fetal/neonatal CCR10^+/EGFP^ mice.(D) Flow cytometric analysis of CCR10 and IL-2, IFN-γ, TNF-α, granzyme B, or IL-17A in gated CD3^−^NK1.1^+^ thymocytes of fetal/neonatal CCR10^+/EGFP^ mice. Data are representative of at least four experiments.(E) Flow cytometric analysis of CCR10 and transcription factors Eomes and PLZF in gated CD3^−^NK1.1^+^ thymocytes of fetal/neonatal CCR10^+/EGFP^ mice. Data are representative of at least four independent experiments.(F) Flow cytometric analysis of CCR10 and indicated lineage markers on gated CD3^−^NK1.1^+^ thymocytes of fetal/neonatal CCR10^+/EGFP^ mice. Data are representative of at least four experiments.(G) Flow cytometric analysis of gated CCR10(EGFP)^+^CD3^-^ thymocytes (left) of fetal/neonatal CCR10^+/EGFP^ mice for their expression of NK1.1 (right). Data are representative of at least four experiments.

We further characterized the CCR10^+^ fetal/neonatal thymic NK1.1^+^ innate lymphocytes. All or most of CCR10^+^ thymic CD3^−^NK1.1^+^ cells expressed the cell surface molecules CD127, CD122, CD90, CD49a, and DX5, but not CD11b or NKp46 ([Figure 1](#fig1){ref-type="fig"}C). A large fraction co-expressed CD127, a marker for helper ILCs, and DX5, a marker of cNK cells ([Figure S1](#mmc1){ref-type="supplementary-material"}A). They could produce high levels of IL-2, IFN-γ, and TNF-α, but not grzmB or IL-17, when stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin ([Figure 1](#fig1){ref-type="fig"}D). CCR10^+^ thymic CD3^−^NK1.1^+^ cells expressed PLZF and Eomes, the transcription factors commonly associated, respectively, with ILCs and NK cells ([Figure 1](#fig1){ref-type="fig"}E) ([@bib11], [@bib10], [@bib15], [@bib34], [@bib46], [@bib53]). All these cells also expressed T-bet, a transcription factor associated with ILC1s and cNK cells, and many expressed GATA3, a transcription factor important for thymic NK development ([Figure S1](#mmc1){ref-type="supplementary-material"}B) ([@bib58]). These results indicate that CCR10^+^ fetal/neonatal thymic NK1.1^+^ ILCs are a unique population of ILC1s with overlapping features of NK cells. Notably, unlike other ILC subsets, the CCR10^+^ NK1.1^+^ ILC1s were Lin^+^ and mostly expressed the "B cell lineage marker" B220, but not Gr1 or CD5 ([Figure 1](#fig1){ref-type="fig"}F). They did not express IgM or CD19, confirming that they were not contaminated B cells ([Figure S1](#mmc1){ref-type="supplementary-material"}C). CCR10^+^ NK1.1^+^ ILC1s accounted for most CCR10^+^ CD3^-^ fetal/neonatal thymocytes, suggesting that they are the major skin-homing ILC subset generated in fetal/neonatal thymi ([Figure 1](#fig1){ref-type="fig"}G).

NK1.1^+^ ILC1s Are Highly Enriched in the Skin of Newborn Mice {#sec2.2}
--------------------------------------------------------------

We then determined whether there was preferential enrichment of NK1.1^+^ ILC1s in the skin during early ontogenic stages. Indeed, in late fetal (E18) and newborn (day 1--4) mice, CD3^−^NK1.1^+^ cells accounted for more than 10% of skin CD45^+^ immune cells and a significant percentage (20%--30%) expressed CCR10 ([Figures 2](#fig2){ref-type="fig"}A and 2B). The percentage of CD3^−^NK1.1^+^ cells of total skin CD45^+^ cells gradually decreased in adult mice ([Figures 2](#fig2){ref-type="fig"}C and 2D). In addition, a smaller fraction of adult skin CD3^−^NK1.1^+^ CD45^+^ cells expressed CCR10 than neonatal skin CD3^−^NK1.1^+^ CD45^+^ cells ([Figure 2](#fig2){ref-type="fig"}E). In contrast to the skin, CD3^−^NK1.1^+^ cells of intestines did not express CCR10 ([Figures 2](#fig2){ref-type="fig"}B and 2E). Associated with these, CD3^−^NK1.1^+^ cells of intestine-draining mesenteric lymph nodes did not express CCR10, whereas a small fraction of CD3^−^NK1.1^+^ cells of sLNs expressed CCR10 ([Figure 2](#fig2){ref-type="fig"}E). No CD3^−^NK1.1^+^ cells of spleens or livers of any ontogenic stage expressed CCR10 ([Figures 2](#fig2){ref-type="fig"}B and 2E). These results demonstrate that CCR10^+^ CD3^+^NK1.1^+^ cells are skin-specific ILCs preferentially enriched in the skin of fetal/neonatal mice. Further analysis confirmed that neonatal skin CCR10^+^ NK1.1^+^ ILCs had the same molecular expression pattern of cell surface markers, ability of cytokine production, and expression of the transcription factors PLZF and Eomes as the thymic CCR10^+^ NK1.1^+^ ILC1s ([Figures 2](#fig2){ref-type="fig"}F--2I, summarized in [Table S1](#mmc1){ref-type="supplementary-material"}), also supporting the notion that preferential generation of skin-homing NK1.1^+^ ILC1s in fetal/neonatal thymi contributes to specific enrichment of NK1.1^+^ ILC1s in the neonatal skin.Figure 2NK1.1^+^ ILC1s Accounted for a Higher Percentage of Lymphocytes in the Skin of Fetal/Neonatal Mice than of Adult Mice(A) Flow cytometric detection of CD3^−^NK1.1^+^ cells in gated CD45^+^ lymphocytes of the skin of late fetal (E18) and neonatal (day1--4) CCR10^+/EGFP^ mice. Data are representative of three experiments with at least five mice for each experiment.(B) Flow cytometric analysis of CCR10(EGFP) expression on gated CD3^−^NK1.1^+^CD45.2^+^ cells of the skin, intestine, spleen, and liver of fetal/neonatal CCR10^+/EGFP^ mice. Data are representative of 3--5 experiments.(C) Flow cytometric detection of CD3^−^NK1.1^+^ cells in gated CD45.2^+^ lymphocytes of the skin of 1- and 3-month-old mice.(D) Average percentages of CD3^−^NK1.1^+^ cells of skin CD45^+^ lymphocytes based on the analysis in (C). One dot represents one mouse.(E) Flow cytometric analysis of CCR10(EGFP) expression on gated CD3^−^NK1.1^+^CD45.2^+^ cells of the skin, intestine, spleen, sLN, mesenteric LN (mLN), and liver of adult CCR10^+/EGFP^ mice. Representative of at least 10 experiments for skin, sLN, mesenteric LN (mLN), spleen, and liver.(F--I) Flow cytometric analysis of the expression of CCR10 and indicated molecules in gated CD3^−^NK1.1^+^CD45.2^+^ cells of the skin of newborn CCR10^+/EGFP^ mice. Data are representative of at least two experiments.(J) Flow cytometric analysis of the CD127 and CD11b expression on gated CCR10^+^ and CCR10^-^ CD3^−^NK1.1^+^CD45.2^+^ cells of sLNs of adult CCR10^+/EGFP^ mice. Data are representative of at least 10 experiments.(K) Comparison of percentages and numbers of the CCR10^+^ and CD127^+^CD11b^−^ CD3^−^NK1.1^+^ cells in the skin, sLN, and thymus of adult CCR10^+/EGFP^ mice fed with FTY720 (FTY) or not (Ctrl). One dot represents one mouse.(L) Flow cytometric analysis of gated EGFP^+^ CD3^-^ CD45^+^ cells of newborn and adult skin and adult sLNs of CCR10^+/EGFP^ mice for their expression of NK1.1.Data are representative of at least three experiments. NS, not significant, ∗∗p \< 0.01, ∗∗∗p \< 0.001 as determined by two-tailed Student\'s t test.

CCR10^+^ CD3^−^NK1.1^+^ cells in the skin of adult mice were more heterogeneous than CCR10^+^ NK1.1^+^ ILC1s of the fetal/neonatal skin and thymus ([Figure S2](#mmc1){ref-type="supplementary-material"}A, [Table S1](#mmc1){ref-type="supplementary-material"}), suggesting that they had more diverse sources of origins and/or activation statuses. As we previously found that the sLN is a site supporting generation of CCR10^+^ skin-homing ILC2/3s in adult mice ([@bib64]), we tested whether CCR10^+^ CD3^−^NK1.1^+^ cells of sLNs also contributed to skin NK1.1^+^ ILC1s in adult mice. Consistent with this notion, the majority of CCR10^+^ CD3^−^NK1.1^+^ cells of adult sLNs were CD127^+^ ILC1s, whereas CCR10^−^CD3^−^NK1.1^+^ cells were mostly CD127^−^CD11b^+^ cNK cells ([Figure 2](#fig2){ref-type="fig"}J and [Table S1](#mmc1){ref-type="supplementary-material"}). Furthermore, after treatment with FTY720, a drug that blocks the migration of ILCs of the sLNs and thymus ([@bib40], [@bib64]), percentages of CCR10^+^ NK1.1^+^ ILC1s increased in the sLNs but decreased in the skin compared with untreated controls ([Figures 2](#fig2){ref-type="fig"}K and [S2](#mmc1){ref-type="supplementary-material"}B), confirming that CCR10^+^ ILC1s of the sLNs migrate into the skin to contribute to the skin NK1.1^+^ ILC1 pool. The FTY720 treatment also increased the percentage of CCR10^+^ NK1.1^+^ ILCs in adult thymi compared with untreated controls ([Figures 2](#fig2){ref-type="fig"}K and [S2](#mmc1){ref-type="supplementary-material"}B), indicating that although generation of skin-homing CCR10^+^ NK1.1^+^ ILC1s is drastically lower in adult than fetal thymi, inhibition of their egress results in accumulation of these cells in adult thymi. These results suggest that skin-homing NK1.1^+^ ILC1s of thymi could still contribute to the skin ILC repertoire in adult mice, although the relative contribution is much less than during perineonatal stages. In agreement, CCR10^+^ NK1.1^+^ ILC1s accounted for only a very small fraction (2%--5%) of total CCR10^+^ ILCs in the skin or sLNs of adult mice, whereas they accounted for the majority (\>50%) of CCR10^+^ ILCs in the neonatal skin ([Figure 2](#fig2){ref-type="fig"}L). Together, these results revealed distinct mechanisms for establishment of different ILC populations in the skin of neonatal versus adult stages.

Unique Thymic Environments and Progenitor Cells Determine Preferential Generation of Skin-Homing NK1.1^+^ ILC1s in Fetal/Neonatal Mice {#sec2.3}
--------------------------------------------------------------------------------------------------------------------------------------

Both unique thymic environments and intrinsic properties of progenitor cells could play a role in the preferential generation of skin-homing NK1.1^+^ ILC1s in fetal/neonatal thymi compared with adult thymi or other primary lymphoid organs. One major difference between fetal and adult thymic environments is that the adult thymus is dominated by a large number of developing T cells, which are much less abundant in fetal thymi. We therefore tested whether absence of T cells in thymi of adult Rag1^−/−^ mice would increase generation of CCR10^+^ NK1.1^+^ ILC1s. Strikingly, most thymic CD3^−^NK1.1^+^ cells of adult Rag1^−/−^ mice expressed CCR10(EGFP^+^), which markedly contrasted to those of adult wild-type (WT) mice ([Figures 1](#fig1){ref-type="fig"}A and [3](#fig3){ref-type="fig"}A). CCR10^+^ thymic CD3^−^NK1.1^+^ cells of adult Rag1^−/−^ mice expressed CD127, CD103, integrin β7, and other markers associated with skin-homing ILC1s ([Figures 3](#fig3){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}A). On the contrary, CD3^−^NK1.1^+^ cells of the BM of adult Rag1^−/−^ mice remained CCR10(EGFP) negative ([Figure 3](#fig3){ref-type="fig"}B). These results indicate that thymic, but not BM, environments specifically support the generation of skin-homing NK1.1^+^ ILCs, which, however, is suppressed by a large number of developing T cells in the adult thymi. Associated with the increased generation of skin-homing NK1.1^+^ ILC1s in the thymi of adult Rag1^−/−^ mice, percentages and numbers of CCR10^+^ NK1.1^+^ ILCs also increased in the sLNs compared with those of WT mice ([Figure 3](#fig3){ref-type="fig"}C). A large fraction of CCR10^+^ NK1.1^+^ ILCs in the sLNs of adult Rag1^−/−^ mice expressed B220, whereas those in the thymi of adult Rag1^−/−^ mice expressed only low levels of B220 ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Total numbers of CCR10^+^ NK1.1^+^ ILCs in the skin of adult Rag1^−/−^ mice increased compared with WT controls, although percentages of the CCR10^+^ subset of total CD3^−^NK1.1^+^ cells decreased compared with WT controls ([Figure 3](#fig3){ref-type="fig"}C), which is consistent with our previous finding that skin ILC2/3s downregulate CCR10 upon activation in response to local environmental changes in the absence of T cells in Rag1^−/−^ mice ([@bib64]).Figure 3Different Thymic Environments and Progenitor Cells Determine Preferential Generation of CCR10^+^ NK1.1^+^ ILC1s in Fetal/Neonatal Versus Adult Thymi(A) Flow cytometric analysis of CD3^−^NK1.1^+^ thymocytes of adult Rag1^−/−^CCR10^+/EGFP^ mice for CCR10(EGFP) and CD127 expression. The dot graph compares the percentages of CCR10^+^ subset of CD3^−^NK1.1^+^ thymocytes in Rag1^−/−^CCR10^+/EGFP^ and CCR10^+/EGFP^ controls. One dot represents one mouse.(B) Flow cytometric analysis of CD3^−^NK1.1^+^ cells from the BM of adult Rag1^−/−^CCR10^+/EGFP^ mice for their CCR10(EGFP) and CD127 expression.(C) Comparison of percentages and numbers of the CCR10^+^CD127^+^ subset of CD3^−^NK1.1^+^ cells in the sLNs and skin of Rag1^−/−^CCR10^+/EGFP^ mice and corresponding CCR10^+/EGFP^ controls. One dot represents one mouse.(D) Flow cytometric detection of CD3^−^NK1.1^+^ cells of gated CD45^+^ cells of fetal liver and adult BM donor progenitors in indicated tissues of the same recipient mice analyzed 2 months after transfer.(E) Comparison of percentages of CD3^−^NK1.1^+^ cells and CD3^+^ T cells of fetal and adult donor-derived CD45^+^ cells in indicated tissues.One dot represents one mouse. NS, not significant, ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p \< 0.001 as determined by two-tailed Student\'s t test.

To test whether fetal progenitor cells gave rise to skin-homing NK1.1^+^ ILC1s more efficiently than adult progenitor cells, we reconstituted irradiated adult WT mice with co-transfer of fetal liver and adult BM progenitor cells. Similar percentages of CD3^−^NK1.1^+^ cells of fetal and adult donor progenitors were found in the BM of recipients 2 months after reconstitution ([Figures 3](#fig3){ref-type="fig"}D and 3E), consistent with the previous findings that adult progenitor cells replace the fetal progenitor cells within 2--4 weeks after birth to become the dominant source of lymphocyte development in adults ([@bib32]) ([@bib66]). As in adult WT mice, few CD3^−^NK1.1^+^ cells of the fetal or adult donor origin were found in the thymi of recipients ([Figures 3](#fig3){ref-type="fig"}D and 3E). However, in peripheral sites, CD3^−^NK1.1^+^ cells of fetal donor progenitors were found at much higher percentages in the skin, sLNs, and spleens of recipients than those of adult donor progenitors, whereas percentages of fetal donor-derived T cells were lower than those of adult donor-derived T cells ([Figures 3](#fig3){ref-type="fig"}D and 3E). Notably, the difference between percentages of fetal versus adult donor-derived CD3^−^NK1.1^+^ cells in the skin (∼5-fold) was significantly greater than that in sLNs (∼2.5-fold) or spleens (∼2-fold) ([Figures 3](#fig3){ref-type="fig"}D and 3E), suggesting that fetal progenitors were more effective in the generation of skin NK1.1^+^ ILCs than adult progenitors. Together, these results demonstrate that unique properties of thymic environments and progenitor cells both contribute to preferential generation of skin-homing NK1.1^+^ ILC1s at fetal/neonatal stages compared with adult stages.

PLZF Is Crucial for Thymic Generation of CCR10^+^ NK1.1^+^ ILC1s and Establishment of Skin NK1.1^+^ ILC1s at Early Postnatal Stages {#sec2.4}
-----------------------------------------------------------------------------------------------------------------------------------

PLZF is a transcription factor highly expressed in CCR10^+^ thymic NK1.1^+^ ILCs ([Figure 1](#fig1){ref-type="fig"}E) and skin NK1.1^+^ ILCs at fetal/neonatal stages ([Figure 2](#fig2){ref-type="fig"}I). Previous studies found that the transient expression of PLZF distinguishes ILCs from NK and LTi cells ([@bib11], [@bib10]). However, PLZF itself is not required for development of most ILCs ([@bib11], [@bib10]). Similarly, PLZF is expressed in the fetal thymic precursors of skin-resident γδT cells, but is not critical for their development ([@bib37]). On the other hand, PLZF is crucial for development of innate-like invariant NK αβT (iNKT) cells, mucosal-associated invariant αβT (MAIT) cells, and a subset of NKT-like γδT cells ([@bib36], [@bib45], [@bib50]). Continuous expression of PLZF in CCR10^+^ NK1.1^+^ thymic and skin ILC1s suggests that it might play a role in their development. To test this, we analyzed PZLF-knockout (KO) mice. The mice also carried a CCR10-KO/EGFP-knockin allele (CCR10^+/EGFP^) to report CCR10 expression with EGFP ([@bib25], [@bib31]). There were similar percentages of total CD3^−^NK1.1^+^ cells in the thymocytes of neonatal wild-type PLZF^+/+^, heterozygous PLZF^+/−^, and homozygous PLZF^−/−^ KO mice ([Figures 4](#fig4){ref-type="fig"}A and 4B). However, within the thymic CD3^−^NK1.1^+^ population, there were greatly reduced percentages of CCR10(EGFP)^+^ NK1.1^+^ ILCs in PLZF^−/−^ mice compared with PLZF^+/+^ controls. PLZF^+/−^ mice also had lower percentages of CCR10(EGFP)^+^ NK1.1^+^ ILCs than PLZF^+/+^ controls ([Figures 4](#fig4){ref-type="fig"}A and 4B). These results demonstrate that PLZF is important for the thymic generation of CCR10^+^ NK1.1^+^ ILCs. Associated with this, there was significant reduction of total as well as CCR10^+^ NK1.1^+^ ILC1s in the skin of PLZF^−/−^ mice compared with PLZF^+/+^ mice, whereas PLZF^+/−^ mice also had modest reduction of the skin NK1.1^+^ ILC1s compared with PLZF^+/+^ mice ([Figures 4](#fig4){ref-type="fig"}C and 4D). These results demonstrate that PLZF is crucial for thymic generation of skin-homing CCR10^+^ NK1.1^+^ ILC1s and establishment of NK1.1^+^ ILC1s in the skin at early postnatal stages.Figure 4PLZF Is Critical for Thymic Generation of Skin-Homing CCR10^+^ NK1.1^+^ ILCs and Establishment of Skin NK1.1^+^ ILCs in Neonatal Mice(A) Flow cytometric detection of CD3^−^NK1.1^+^ thymocytes (top row) and their expression of CCR10(EGFP) and CD11b (bottom row) in neonatal PLZF^+/+^, PLZF^+/−^, and PLZF^−/−^ mice. All mice carry a CCR10-KO/EGFP-knockin allele (CCR10^+/EGFP^) for purpose of reporting CCR10 expression with EGFP.(B) Comparison of the percentages of CD3^−^NK1.1^+^ thymocytes (top) and percentages that express CCR10(EGFP) (bottom) in neonatal PLZF^+/+^, PLZF^+/−^, and PLZF^−/−^ mice. One dot represents one mouse.(C) Flow cytometric detection of CD3^−^NK1.1^+^ cells of gated CD45^+^ skin immune cells (top row) and their expression of CCR10(EGFP) and CD11b (bottom) in neonatal PLZF^+/+^, PLZF^+/−^, and PLZF^−/−^ mice.(D) Comparison of percentages of NK1.1^+^ ILCs of skin CD45+ cells and percentages of skin NK1.1^+^ ILCs that express CCR10(EGFP) in neonatal PLZF^+/+^, PLZF^+/−^, and PLZF^−/−^ mice.One dot represents one mouse. NS, not significant, ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p \< 0.001, and ∗∗∗∗p \< 0.001 as determined by two-tailed Student\'s t test.

Consistent with the finding that PLZF is not crucial for development of skin-resident γδT cells ([@bib37]), there were similar percentages of CCR10(EGFP)^+^ thymic γδT cells in wild-type and PLZF-KO neonatal mice ([Figure S4](#mmc1){ref-type="supplementary-material"}). Therefore, although skin-homing innate-like γδT cells and NK1.1^+^ ILCs are both generated in the fetal/neonatal thymus, they have different dependency on PLZF for their development.

CCR10 in Regulating Migration and Skin Establishment of NK1.1^+^ ILC1s {#sec2.5}
----------------------------------------------------------------------

We previously found that although most skin lymphocytes (αβT, γδT, and ILCs) express CCR10, different subsets have different degrees of dependency on CCR10 for their establishment in the skin, with Treg and CD8^+^ T cells significantly affected and γδT17 cells unaffected by CCR10-KO ([@bib5], [@bib31], [@bib59], [@bib64]). We therefore also tested whether CCR10 was required for skin localization of NK1.1^+^ ILCs. In an *in vitro* migration assay, EGFP^+^ CD3^−^NK1.1^+^ cells of heterozygous CCR10^+/EGFP^ (CCR10^+/−^) mice migrated efficiently toward CCL27, whereas EGFP^+^ CD3^−^NK1.1^+^ cells of homozygous CCR10^EGFP/EGFP^ (CCR10^−/−^) KO mice did not ([Figure S5](#mmc1){ref-type="supplementary-material"}A), indicating that CCR10 is the critical receptor for migration of CCR10^+^ NK1.1^+^ ILCs to the skin-specific ligand CCL27. However, there was no significant difference in percentages of EGFP^+^ NK1.1^+^ ILC1s in the skin of CCR10^+/EGFP^ and CCR10^EGFP/EGFP^ mice at either neonatal or adult stage ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C), suggesting that other homing molecules might compensate for loss of CCR10 in directing these cells to the skin in CCR10-KO mice.

Important Contribution of Fetal/Neonatal-Derived NK1.1^+^ ILC1s to the Skin Immune System {#sec2.6}
-----------------------------------------------------------------------------------------

Fetal/neonatal thymus-derived innate-like γδT cells contribute to a significant fraction of the skin immune cell compartment of mice until adulthood ([@bib23]) ([@bib55]) ([@bib20]) ([@bib4], [@bib5], [@bib49]). As NK1.1^+^ ILCs were generated at the same fetal/neonatal ontogenic stages as innate-like γδT cells, we assessed whether fetal/neonatal-derived NK1.1^+^ ILC1s also had a long-lasting contribution to the establishment of the skin immune system. For this purpose, we injected pregnant mice with anti-NK1.1 antibodies to deplete NK1.1^+^ ILC1s in the developing fetuses ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Although the anti-NK1.1 antibody injection could also deplete other NK1.1-expressing cells, the depletion is mostly specific for NK1.1^+^ ILCs because very few other NK1.1-expressing lymphocytes exist in the skin of neonatal mice ([Figure 1](#fig1){ref-type="fig"}A). Six weeks after birth, the *in utero* antibody-treated mice were analyzed for NK1.1^+^ ILC1s in the skin. Markedly, the *in utero* anti-NK1.1 antibody-treated mice had significantly (2- to 3-fold) reduced percentages and numbers of NK1.1^+^ ILCs in the skin compared with isotype control antibody-treated mice ([Figures 5](#fig5){ref-type="fig"}A, 5B, and [S6](#mmc1){ref-type="supplementary-material"}B). In contrast, the *in utero* NK1.1 antibody-treated mice had similar or only slightly reduced percentages of CD3^−^NK1.1^+^ cells in the BM and spleens compared with the controls ([Figures 5](#fig5){ref-type="fig"}A and 5B). The *in utero* NK1.1 antibody-treated mice also had similar percentages of NK1.1^+^ T cells in the BM, spleen, and skin as isotype control antibody-treated mice ([Figures S6](#mmc1){ref-type="supplementary-material"}C and S6D), indicating that the *in utero* anti-NK1.1 antibody treatment did not significantly affect establishment of NK1.1-expressing T cells in the skin. These results demonstrate that like skin-resident innate-like γδT cells, skin NK1.1^+^ ILC1s are also predominantly derived from fetal/neonatal stages and their *in utero* depletion resulted in defective skin NK1.1^+^ ILCs until adulthood.Figure 5Fetal/Neonatal NK1.1^+^ ILCs Significantly Contribute to the Establishment of the Skin Immune System(A) Flow cytometric detection of CD3^−^NK1.1^+^ cells in gated CD45^+^ lymphocytes of the BM, spleen, and skin of CCR10^+/EGFP^ mice treated *in utero* with anti-NK1.1 or isotype-matched control antibodies. Mice were analyzed 6 weeks after birth.(B) Comparison of the average percentages of CD3^−^NK1.1^+^ cells in BM, spleen, and skin of *in utero* anti-NK1.1 and control antibody-treated mice. One dot represents one mouse. Data are pooled from two independent experiments as performed in (A).(C) Comparison of the percentages (left) and numbers (right) of total CD3^−^NK1.1^+^ cells in thymi of 2- to 3-day-old WT (+/+) or Vγ43^+/−^ versus Vγ43^−/−^ mice. One dot represents one mouse. Data are combined from two litters.(D) Comparison of the percentages and numbers of total and CD90.2^+^ CD3^−^NK1.1^+^CD45^+^CD11b^−^ ILCs in the skin of 10-day-old WT (+/+) or Vγ43^+/−^ versus Vγ43^−/−^ mice.One dot represents one mouse. NS, not significant, ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p \< 0.001 as determined by unpaired two-tailed Student\'s t test. Error bars denote mean ± SD, and data are combined from five separate litters.

Perinatally derived innate-like γδT cells migrate to the skin to help promote local homeostasis ([@bib28], [@bib42]). The preferential establishment of NK1.1^+^ ILCs in the skin at perinatal stages suggests that they might coordinate with innate-like γδT cells to provide early skin immune protection. To further understand this notion, we analyzed NK1.1^+^ ILCs in the skin of Vγ43-KO (Vγ43^−/−^) mice that are devoid of Vγ4^+^ and Vγ3^+^ γδT cells, the two major populations of skin innate-like γδT cells that are generated at fetal stages ([@bib63]). Newborn Vγ43^−/−^ mice had similar percentages of NK1.1^+^ ILCs as WT or heterozygous Vγ43^+/−^ littermates in thymi, suggesting that lack of Vγ4/3^+^ γδT cells did not alter thymic generation of NK1.1^+^ ILCs ([Figure 5](#fig5){ref-type="fig"}C). In striking contrast, there was a significantly increased frequency and number of NK1.1^+^ ILCs in the skin of neonatal Vγ43^−/−^ mice compared with corresponding WT or heterozygous controls ([Figure 5](#fig5){ref-type="fig"}D), suggesting a compensatory expansion of NK1.1^+^ ILCs in the skin in the absence of Vγ4/3^+^ γδT cells, likely in response to local environmental stimulation to help local homeostasis.

NK1.1^+^ ILC1s Actively Respond to the Skin Commensal Bacterial Colonization at the Neonatal Period {#sec2.7}
---------------------------------------------------------------------------------------------------

The skin is immediately colonized by commensal bacteria after birth ([@bib6]). The preferential enrichment and increased expansion of NK1.1^+^ ILC1s in the skin of neonatal WT and Vγ43^−/−^ mice raised the possibility that they might respond to the early commensal bacterial colonization to help local homeostasis. To test this, we compared NK1.1^+^ ILCs in the skin of neonatal mice raised in specific pathogen-free (SPF) versus germ-free (GF) conditions. Notably, neonatal mice raised in SPF conditions had a significantly higher percentage and number of NK1.1^+^ ILCs in the skin than age-matched mice raised in GF conditions ([Figure 6](#fig6){ref-type="fig"}A), suggesting that skin NK1.1^+^ ILCs increased in response to commensal bacterial colonization. Furthermore, compared with skin NK1.1^+^ ILCs of neonatal mice raised in GF conditions, a significantly higher percentage and number of skin NK1.1^+^ ILCs of littermate mice cross-fostered in SPF conditions expressed high levels of grzmC ([Figures 6](#fig6){ref-type="fig"}B and 6C), an effector molecule associated with activated ILC1s ([@bib12], [@bib46]) ([@bib21]). These results demonstrate that skin NK1.1^+^ ILCs actively respond to early commensal bacterial colonization in neonatal mice.Figure 6Skin NK1.1^+^ ILC1s Actively Respond to Bacterial Colonization at Early Postnatal Stages(A) Comparison of percentages and numbers of total and CD127^+^ CD3^−^NK1.1^+^CD45^+^ lymphocytes of the skin of 10-day-old WT mice raised in SPF versus GF conditions.(B) Flow cytometric analysis of skin NK1.1^+^ ILCs of 9-day-old WT neonatal mice raised in SPF versus GF conditions for granzyme C (grzmC) expression. NK1.1^+^ ILCs are gated on CD45^+^CD3^−^NK1.1^+^CD90^+^ lymphocytes.(C) Comparison of average percentages and numbers of grzmC-expressing NK1.1^+^ ILCs in the skin of neonatal mice raised in the SPF versus GF conditions.One dot represents one mouse. Data are combined from two experiments. ∗p \< 0.05, ∗∗p \< 0.01 as determined by Student\'s unpaired two-tailed t test.

NK1.1^+^ ILC1s Play an Important Role in Regulation of Early Commensal Bacterial Colonization of the Skin at the Neonatal Stage {#sec2.8}
-------------------------------------------------------------------------------------------------------------------------------

To demonstrate a direct role of NK1.1^+^ ILCs in the regulation of commensal bacteria, we tested whether *in utero* depletion of NK1.1^+^ cells would result in increased infiltration of commensal bacteria into the deeper tissue such as sLNs ([@bib52]). Pregnant mice were treated with anti-NK1.1 or isotype control antibodies. Ten days after birth, bacteria in the skin and sLNs of the treated mice were assessed by the quantitative PCR analysis of bacterial 16S rRNA gene levels in genomic DNA isolated from the skin and sLNs. Although there was no statistical difference in the levels of bacteria in the skin or sLNs of anti-NK1.1 versus control antibody-treated mice ([Figure S7](#mmc1){ref-type="supplementary-material"}A), anti-NK1.1 antibody-treated mice had a significantly increased ratio of bacteria in the sLNs relative to the skin compared with control-treated mice ([Figure 7](#fig7){ref-type="fig"}A), suggesting that skin NK1.1^+^ ILC1s might be important for barrier defense.Figure 7NK1.1^+^ ILC1s Play an Important Role in Regulating Proper Bacterial Colonization in the Skin at Early Postnatal Stages(A) Comparison of relative levels of commensal bacteria in sLNs versus skin of *in utero* anti-NK1.1 and isotype control antibody-treated WT 9-day-old mice. ∗p \< 0.05 as determined by unpaired two-tailed Student\'s t test.(B) Comparison of bacterial compositions at the phylum level in the skin of *in utero* anti-NK1.1 antibody versus isotype control antibody-treated 10-day-old mice. N = 5 each of anti-NK1.1 and control antibody-treated mice.(C) Comparison of selected bacterial compositions in the skin of *in utero* anti-NK1.1 antibody versus isotype control antibody-treated mice. ∗p \< 0.05, ∗∗p \< 0.01 in the (B and C) as determined by Kruskal-Wallis test.**(**D**--**F**)** Comparison of the total number (D) and frequency (E) of skin NK1.1^+^ ILC1s and their expression of grzmC (F) in neonatal mice topically applied with *P. aeruginosa* or PBS (control) on the skin.One dot represents one mouse. Error bars denote mean ± SD, and data are combined from two experiments. ∗p \< 0.05, ∗∗p \< 0.01 as determined by Student\'s unpaired, two-tailed t test.

We then performed metagenomic analysis to determine how *in utero* depletion of NK1.1^+^ ILCs affected the bacterial composition in the skin of newborn mice. For this, total genomic DNA isolated from the skin of the *in utero* antibody-treated 10-day-old neonates was analyzed by deep sequencing of the PCR products of the bacterial 16S rRNA genes. The composition of commensal bacteria in the skin of anti-NK1.1 and control antibody-treated mice was compared based on the 16S rRNA gene sequencing analysis. Bacteria of the Proteobacteria, Fermicutes, Actinobacteria, and Bacteroidetes phyla dominated the skin of control newborn mice ([Figure S7](#mmc1){ref-type="supplementary-material"}B), similar to that reported in the skin of adult mice ([@bib41]). Compared with the control, the skin of *in utero* anti-NK1.1 antibody-treated mice had significantly decreased bacteria belonging to the phylum Bacteroidetes, whereas the phylum Tenericutes significantly increased ([Figure 7](#fig7){ref-type="fig"}B). Further analysis found that bacteria of the *Pseudomonas* genus and the Mollicutes class were most significantly increased in the skin of anti-NK1.1 antibody-treated mice compared with the controls ([Figures 7](#fig7){ref-type="fig"}C and [S7](#mmc1){ref-type="supplementary-material"}C). These results demonstrate that NK1.1^+^ ILCs regulate homeostatic colonization of commensal bacteria, such as *Pseudomonas*, in the skin at the neonatal stage.

*Pseudomonas aeruginosa* Is a Major Species of Bacteria that Activates Skin NK1.1^+^ ILC1s {#sec2.9}
------------------------------------------------------------------------------------------

Among different species of *Pseudomonas*, *P. aeruginosa* is most clinically relevant. *P. aeruginosa* is commonly present on the skin and mucosal sites such as the nostril and gut of immunocompetent individuals as commensals ([@bib9]). The newborn may acquire *P. aeruginosa* from the mother through birth, but is capable of controlling their homeostatic colonization. As commensals, *P. aeruginosa* may have beneficial effects on hosts by inhibiting pathogenic microorganisms. However, *P. aeruginosa* could become a pathogen in immunocompromised hosts ([@bib9], [@bib39]), suggesting that the immune system is crucial to maintain homeostasis of the bacteria and hosts. Considering the clinical importance of *P. aeruginosa*, we directly tested whether NK1.1^+^ ILC1s responded to *P. aeruginosa* inoculation on the skin of newborn mice. Neonatal littermates were topically applied with *P. aeruginosa* or PBS (control) on the skin for 2 consecutive days and were analyzed 5 days later. Notably, although the percentage and number of NK1.1^+^ ILC1s were unaltered or only slightly increased in the skin that was topically applied with *P. aeruginosa* compared with the PBS-applied control ([Figures 7](#fig7){ref-type="fig"}D and 7E), the percentage of grzmC-expressing NK1.1^+^ ILC1s in the *P. aeruginosa*-inoculated skin was significantly higher than that in the PBS-treated controls ([Figure 7](#fig7){ref-type="fig"}F). These results indicate that NK1.1^+^ ILCs actively respond to the *P. aeruginosa* colonization and could be potentially involved in regulation of the bacteria in the skin at neonatal stages.

Discussion {#sec3}
==========

The skin is exposed to commensal bacteria and other environment insults immediately after birth. How skin-resident immune cells are established at early postnatal stages to protect the skin and maintain the local homeostasis is not well understood. Here, we found that perinatal thymus-derived NK1.1^+^ ILC1s preferentially acquire skin-homing properties and contribute to regulation of commensal bacterial colonization in the skin of newborn mice, revealing differing mechanisms of development and function of skin-resident ILCs at early postnatal stages than at adult stages when sLN-generated skin-homing NK1.1^-^ ILC2/3s contribute to their dominance in the skin ([@bib64]).

CD3^−^NK1.1^+^ cells were found in the thymi of both fetal and adult mice long ago and were considered as a population of NK cells ([@bib7], [@bib58]). The thymic NK cells can be found as early as day 13 of gestation in mice ([@bib7]). Until recently, it was not clear whether fetal thymic NK cells are a distinct population of innate lymphocytes. Studies of adult thymic NK cells found that they are different from cNK cells because thymic NK cells depend on GATA3 and IL-7 for their development ([@bib58]). Thymic NK cells also express Eomes and develop independent of T-bet ([@bib16]). Unlike cNK cells, thymic NK cells do not express CD11b, whereas they both express DX5 and NKG2D. When stimulated with PMA/ionomycin, thymic NK cells express higher IFN-γ and TNF, but lower grzmB than cNK cells ([@bib58]). Based on these features, adult thymic NK cells are closely related to the CCR10^+^ fetal/neonatal thymic NK1.1^+^ ILCs we describe herein. However, because CCR10^+^ fetal/neonatal thymic NK1.1^+^ ILCs depend on PLZF for their development, we conclude that they are ILC1s, but not NK cells ([@bib11], [@bib10]). Additional studies are needed to establish their relationship with adult thymic NK cells. Interestingly, whereas few thymic NK cells of adult mice express CCR10, the majority of thymic NK1.1^+^ cells of adult Rag1^−/−^ mice expressed CCR10, indicating that they may be more related to fetal/neonatal CCR10^+^ ILC1s. However, there are some differences between CCR10^+^ NK1.1^+^ thymocytes of adult Rag1^−/−^ mice and fetal/neonatal NK1.1^+^ ILC1s. Most CCR10^+^ fetal/neonatal NK1.1^+^ ILC1s express B220, but not NKp46, whereas the adult CCR10^+^ NK1.1^+^ thymocytes express NKp46, but low B220. Interestingly, CCR10^+^ NK1.1^+^ cells in sLNs of adult Rag1^−/−^ mice highly express B220. As thymic NK cells are suggested to preferentially export into peripheral LNs, including sLNs ([@bib58]), it is possible that the CCR10^+^ adult thymic NK cells could differentiate further in the sLN environments before their localization into the skin.

It is notable that fetal/neonatal thymus preferentially supports the generation of skin-homing ILCs and innate-like γδT cells. However, molecular mechanisms involved in their generation are not identical. We previously reported that T cell receptor-derived signals are required for the upregulation of CCR10 on skin-homing innate-like γδT cells in the thymi ([@bib30], [@bib31], [@bib61]). However, the molecular mechanisms involved in the thymus-specific generation of CCR10^+^ NK1.1^+^ ILC1s have yet to be defined. Considering that thymic, but not BM, environments support the generation of skin-homing NK1.1^+^ ILCs, it is plausible to hypothesize that thymic stroma-specific molecular signals are required for the generation of skin-homing NK1.1^+^ ILCs. Possible candidates include Notch ligands that are known to be highly expressed in thymic, but not BM, stromal cells ([@bib1], [@bib27], [@bib43], [@bib56], [@bib60]). Our finding that developing T cells suppress the generation of CCR10^+^ NK1.1^+^ ILC1s in adult thymi is consistent with the notion that a Notch/ligand signal may be involved in the preferential generation of skin-homing CCR10^+^ NK1.1^+^ ILC1s in fetal and neonatal thymi where fewer developing T cells compete for interaction with Notch ligands expressed on thymic stromal cells. Whether and how different Notch ligands and receptors are involved in the thymic generation of skin-homing NK1.1^+^ ILC1s remains to be determined. In addition, PLZF is critical for the thymic generation of CCR10^+^ NK1.1^+^ ILCs, but not CCR10^+^ γδT cells, also suggesting different mechanisms for their development.

While the unique thymic environment supports generation of skin-homing NK1.1^+^ ILC1s at perinatal stages, our previous studies found that sLNs also support generation of skin-homing ILCs in adult mice ([@bib64]). However, sLNs in adult mice preferentially support generation of skin-homing ILC2/3s and may not be a major site for the generation of skin-resident NK1.1^+^ ILCs. Consistent with this notion, depletion of NK1.1^+^ ILCs *in utero*, when the sLNs are not well developed or functional, severely impaired the establishment of skin NK1.1^+^ ILCs until adulthood, demonstrating that most NK1.1^+^ ILCs in the skin originate at perinatal stages. However, the exact contribution of fetal/neonatal thymus-derived skin-homing NK1.1^+^ ILCs to the total skin NK1.1^+^ ILC repertoire is not clear. Many NK1.1^+^ ILCs of the neonatal skin do not express CCR10. Although it is possible that CCR10^+^ ILCs differentiate into CCR10^-^ ILCs upon activation in the skin ([@bib64]), it could not be ruled out that CCR10^-^ NK1.1^+^ ILCs originate from different developmental processes and/or origins. The relationship of CCR10^+^ and CCR10^-^ NK1.1^+^ skin ILCs needs further investigation.

The enrichment of NK1.1^+^ ILC1s in the skin at early postnatal stages is important in the regulation of commensal bacterial colonization. Compared with skin NK1.1^+^ ILC1s of neonatal mice raised in GF conditions, skin NK1.1^+^ ILC1s of neonatal mice raised in SPF conditions are more active, indicated by increased grzmC expression. Skin NK1.1^+^ ILC1s also had increased expression of grzmC in response to over-population with *Pseudomonas aeruginosa*. The increased grzmC expression by activated ILC1s in regulation of bacterial colonization has yet to be determined. Potentially, the molecule could help regulate proper bacterial colonization by killing bacterium-infected cells or targeting bacteria directly ([@bib3], [@bib13], [@bib17]). In addition, cytokines produced by NK1.1^+^ ILC1s, such as IFN-γ, could stimulate other immune and non-immune cells for the production of antimicrobial molecules. Interestingly, activated NK1.1^+^ ILC1s express grzmC but not grzmB, indicating that they use different effector mechanisms to protect the host than NK cells, which preferentially express grzmB over grzmC ([@bib3]). The differential expression of granzymes in ILC1s and NK cells might be relevant to their different, but compensatory, functions. Functional compensation of NK1.1^+^ ILC1s and innate-like γδT cells was also identified in our current study, as NK1.1^+^ ILC1s expanded in the skin of neonatal mice deficient in Vγ3/Vγ4^+^ γδT cells. Mechanisms of functional compensation and coordination of different innate or innate-like lymphocytes in the skin homeostatic regulation require further investigation.

Early immune cell development plays a critical role in the establishment of long-term immune homeostasis. Disturbance of perinatal immune cell development has lasting effects on the health of individuals and could be a causative factor in the development of autoimmune diseases in adults ([@bib2]). We found that perinatally derived NK1.1^+^ ILCs have long-lasting contribution to the skin immune cell repertoire until adulthood. However, this population steadily decreases with increase in age. By age 3 months, NK1.1^+^ ILCs account for a very minor population (\<1%) of total lymphocytes in the skin. These suggest that the perinatal generation of NK1.1^+^ ILC1s represents a temporally regulated developmental mechanism to provide rapid innate immune protection of the skin at the early postnatal stage, when adaptive immune cells are not well developed. In the adult skin, NK1.1^+^ ILC1s may be less required likely because adaptive T cells could functionally substitute for NK1.1^+^ ILC1s. Consistent with this notion, there are increased NK1.1^+^ ILC1s in the skin of adult Rag1^−/−^ mice, which lack adaptive immune T/B cells.

Limitations of the Study {#sec3.1}
------------------------

The functional importance and mechanisms of skin-resident NK1.1^+^ ILC1s in helping establishment of the skin homeostasis throughout early postnatal stages require further investigation. In our experiments of using anti-NK1.1 antibodies to deplete NK1.1^+^ ILC1s to study their roles in regulating the local tissue homeostasis and commensal bacterial colonization in the skin of neonatal mice, the antibody treatment is not completely specific to NK1.1^+^ ILC1s because it could target the other NK1.1-expressing cells such as cNK and iNKT cells. Therefore, although NK1.1^+^ ILC1s account for the majority of NK1.1-expressing immune cells in the neonatal skin, it could not be ruled out that the other NK1.1-expressing immune cells also contributed to the increased *Pseudomonas* species observed in the anti-NK1.1 antibody-treated wild-type mice. Additional studies are needed to confirm that NK1.1^+^ ILC1s play a crucial role in regulating the skin colonization or infection of *P. aeruginosa*. Potentially, these conclusions could be strengthened if specific ILC1-deficient mice have increased *P. aeruginosa* colonization. However, currently there is no specific method to deplete only ILC1s from mice for the study. Molecular mechanisms underlying activation and function in response to the commensal colonization are also yet to be determined.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Code Availability {#appsec1}
==========================

The data will be deposited into the ImmPort ([www.Immport.org](http://www.immport.org){#intref0010}) for public access.
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